Skip to main content
. 2013 May;73(5):433–439. doi: 10.1055/s-0032-1328612

Fig. 1.

Fig. 1

 Question: “Which neoadjuvant regimen are you most likely to use in this situation?” EC – epirubicin, cyclophosphamide; DC – docetaxel, cyclophosphamide; FEC – fluorouracil, epirubicin, cyclophosphamide; TAC – docetaxel, adriamycin, cyclophosphamide.